New variants in beta globin gene among the Palestinian refugees with sickle cell disease in Lebanon

References

1. ↵
   1. Kohne E

   (2011) Hemoglobinopathies:clinical manifestations, diagnosis, and treatment. Dtsch Arztebl Int 108:532–540.

   OpenUrlPubMed
2. ↵
   1. Bunn HF,
   2. Forget BG

   (1986) Hemoglobin:Molecular, genetic and clinical aspects (W. B. Saunders Company, Philadelphia (PA)), p 690.
3. ↵
   1. Ashley-Koch A,
   2. Yang Q,
   3. Olney RS

   (2000) Sickle hemoglobin (Hb S) allele and sickle cell disease:a HuGE review. American Journal of Epidemiology 151:839–845.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Diez-Silva M,
   2. Dao M,
   3. Han J,
   4. Lim CT,
   5. Suresh S

   (2010) Shape and biomechanical characteristics of human red blood cells in health and disease. MRS Bull 35:382–388.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Thom CS,
   2. Dickson CF,
   3. Gell DA,
   4. Weiss MJ

   (2013) Hemoglobin variants:biochemical properties and clinical correlates. Cold Spring Harb Perspect Med 3:a011858.

   OpenUrlAbstract/FREE Full Text
6. ↵
   1. El-Hazmi MAF,
   2. Al-Hazmi AM,
   3. Warsy AS

   (2011) Sickle cell disease in Middle East Arab countries. Indian J Med Res 134:597–610.

   OpenUrlCrossRefPubMed
7. ↵
   1. Cheung MC,
   2. Goldberg JD,
   3. Kan YW

   (1996) Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 14:264–268.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Charache S,
   2. Dover GJ,
   3. Moore RD,
   4. Eckert S,
   5. Ballas SK,
   6. Koshy M,
   7. et al.

   (1992) Hydroxyurea:effects on hemoglobin F production in patients with sickle cell anemia. Blood 79:2555–2565.

   OpenUrlAbstract/FREE Full Text
9. ↵
   1. Constantoulakis P,
   2. Knitter G,
   3. Stamatoyannopoulos G

   (1989) On the induction of fetal hemoglobin by butyrates:in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC. Blood 74:1963–1971.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Saunthararajah Y,
    2. Hillery CA,
    3. Lavelle D,
    4. Molokie R,
    5. Dorn L,
    6. Bressler L,
    7. et al.

    (2003) Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. Blood 102:3865–3870.

    OpenUrlAbstract/FREE Full Text
11. ↵
    1. Little JA,
    2. McGowan VR,
    3. Kato GJ,
    4. Partovi KS,
    5. Feld JJ,
    6. Maric I,
    7. et al.

    (2006) Combination erythropoietin-hydroxyurea therapy in sickle cell disease:experience from the National Institutes of Health and a literature review. Haematologica 91:1076–1083.

    OpenUrlAbstract/FREE Full Text
12. ↵
    1. Bolaños-Meade J,
    2. Brodsky RA

    (2009) Blood and marrow transplantation for sickle cell disease:overcoming barriers to success. Curr Opin Oncol 21:158–161.

    OpenUrlCrossRefPubMed
13. ↵
    1. Rumaney MB,
    2. Ngo Bitoungui VJ,
    3. Vorster AA,
    4. Ramesar R,
    5. Kengne AP,
    6. Ngogang J,
    7. et al.

    (2014) The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival. PLoS One 9:e100516.

    OpenUrl
14. ↵
    1. El-Hazmi MA,
    2. Warsy AS

    (1999) Pattern for alpha-thalassaemia in Yemeni sickle-cell-disease patients. East Mediterr Health J 5:1159–1164.

    OpenUrlPubMed
15. ↵
    1. Al-Ghazaly J,
    2. Al-Dubai W,
    3. Abdullah M,
    4. Al-Mahagri A,
    5. Al-Gharasi L

    (2013) Characteristics of sickle cell anemia in Yemen. Hemoglobin 37:1–15.

    OpenUrlCrossRefPubMed
16. ↵
    1. Inati A,
    2. Jradi O,
    3. Tarabay H,
    4. Moallem H,
    5. Rachkidi Y,
    6. El Accaoui R,
    7. et al.

    (2007) Sickle cell disease:the Lebanese experience. Int J Lab Hematol 29:399–408.

    OpenUrlPubMed